FST and metabolic dysfunction-associated steatotic liver disease: Hepatokine involvement through FXR/RXR signaling pathway in NAFLD and NASH includes FGF21, HMBG1, DPP4, RBP4, FST, AHSG, SERPINF, SHBG, LECT2 and SELENOP.